Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability

α1-Adrenergic receptor antagonists are commonly used to treat male lower urinary tract symptoms and benign prostatic hyperplasia (BPH). We performed a literature search using PubMed, Medline via Ovid, Embase, and the Cochrane Library databases to identify studies on the treatment of BPH by silodosin...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hee Ju, Yoo, Tag Keun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199653/
https://www.ncbi.nlm.nih.gov/pubmed/25328864
http://dx.doi.org/10.2147/RRU.S41618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199653/
https://www.ncbi.nlm.nih.gov/pubmed/25328864
http://dx.doi.org/10.2147/RRU.S41618

Ejemplares similares